Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

We recently published a list of 15 Best Dividend Stocks To Buy and Hold. In this article, we are going to take a look at ...

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other dividend stocks ...

The use of a continuous glucose monitor during pregnancy may be more cost-effective than self-monitoring blood glucose for ...

Smart dosing for diabetes patients “is expected to dominate by the end of the decade, as CGM alone is just not sufficient for this patient population ... diabetes management off their plates,” he ...

Trinity Biotech (Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system. Dublin, Ireland-based Trinity’s trial included 30 ...

United States Continuous Glucose Monitoring (CGM ... optional real-time alarms for users to monitor their glucose levels more effectively. Medtronic rounds out the trio of key players ...

Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...

Since the start of 2025, Medtronic plc (NYSE:MDT) has surged by nearly 10%. Earlier this year, the company secured US approval for its Simplera continuous glucose monitoring (CGM) system. In ...

Medtronic has agreed to be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes devices that provide revascularization treatment for carotid and peripheral vascular disease.

In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other dividend stocks. Dividend stocks, while popular among investors, have been underperforming ...